Action Medigene () - MDGEF

Medigene AG () (MDGEF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,10

( - )

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Cap du marché

1,489M

Clôture Veille

0,10

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

US$ 6 005

Actions en circulation

14 887 594

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,02

Bénéfice par action (BPA)

-1,26

Chiffre d'affairess (LTM)

7,45M

Bénéfice net (LTM)

-15,93M

Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany. Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.

Secteur

Finance

Industrie

Asset Management Services

Site Web

www.medigene.com

Siège social

Munich, Germany

Fondé

1994

Medigene AG () est coté dans le secteur Finance de la OTC Markets avec le ticker MDGEF. Le dernier cours de clôture d'Medigene () était de US$0,10. Au cours de la dernière année, les actions de Medigene () ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Medigene () compte actuellement 14 887 594 actions en circulation. La capitalisation boursière d'Medigene () est de US$1,49 million. Medigene () a un ratio cours/bénéfice (ratio PE) de -0.02.

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

* Total revenues increased by 50% to 19.7 million euro (2004: 13.1 million euro) * Operating loss (EBIT) reduced by 22% to -11.5 million euro...

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MARTINSRIED, Germany and SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- The Executive Board of the German-American biotech company MediGene AG...

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

- MediGene Receives Milestone Payment for Launch in France - MediGene's First Drug* Now Available in 11 European Countries MARTINSRIED, Germany...

MediGene to Present at BIO CEO & Investor Conference in New York City

MARTINSRIED/MUNICH, Germany and SAN DIEGO, Feb. 14 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (German Stock...

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

* Bradley acquires US commercialization rights for genital warts and other dermatological diseases. MediGene retains full rest of world...

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

* A non-exclusive license under existing tumor-vaccine patents MARTINSRIED, Germany and MUNICH, Germany, and SAN DIEGO, Dec. 19...

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MARTINSRIED and MUNICH, Germany and SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (Frankfurt...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MDGEF - Frequently Asked Questions (FAQ)

What is the current Medigene AG () share price?

The current share price of Medigene AG () is US$ 0,10

How many Medigene AG () shares are in issue?

Medigene AG () has 14 887 594 shares in issue

What is the market cap of Medigene AG ()?

The market capitalisation of Medigene AG () is USD 1,49M

What is the 1 year trading range for Medigene AG () share price?

Medigene AG () has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Medigene AG ()?

The price to earnings ratio of Medigene AG () is -0,02

What is the cash to sales ratio of Medigene AG ()?

The cash to sales ratio of Medigene AG () is 0,04

What is the registered address of Medigene AG ()?

The registered address for Medigene AG () is Lochhamer Strasse 11, Munich, Bavaria, 82152

What is the Medigene AG () website address?

The website address for Medigene AG () is www.medigene.com

Which industry sector does Medigene AG () operate in?

Medigene AG () operates in the Asset Management Services sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medigene AG () (MDGEF)

Medigene AG () (MDGEF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Medigene AG ()

MDGEF Dernières nouvelles

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

MediGene to Present at BIO CEO & Investor Conference in New York City

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MediGene AG Announces 6-Months Result and Confirms Forecast for the Year

MDGEF - Frequently Asked Questions (FAQ)

MDGEF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medigene AG () (MDGEF)

Medigene AG () (MDGEF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Medigene AG ()

MDGEF Dernières nouvelles

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

MediGene to Present at BIO CEO & Investor Conference in New York City

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MediGene AG Announces 6-Months Result and Confirms Forecast for the Year

MDGEF - Frequently Asked Questions (FAQ)

MDGEF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS